Devastating voice loss (dysphonia or aphonia) impacts thousands of individuals in the United States each year undergoing traumatic or oncologic partial laryngectomies, or suffering muscle volume loss due to vocal fold paralysis. Voice restoration options for these patients are suboptimal, and, as a result, most patients are left with permanent voice loss and communication impairment. This application introduces a novel approach for restoring vocal fold muscle volume and function after direct vocal fold injury and/or denervation. Results may lead to improved surgical options for voice restoration in patients who have vocal paralysis and/or have undergone hemilaryngectomies, cordectomies, or traumatic avulsions. The first goal of this application is to develop a muscle progenitor cell-derived implant (MI) that, after implantation in an animal model, receives strong innervation. Specifically, the effect of myofiber motor endplate expression on post-implantation innervation of MIs will be determined. To do this, we will fabricate and pre-treat MIs with factors in vitro that induce the MI muscle to express motor endplates. The MIs will be used to replace a partial laryngectomy defect in a syngeneic rat model, and post-implantation innervation status, based on laryngeal electromyography and quantification of motor endplates with nerve contact, will be determined. Using this animal implant model, outcomes with the study MIs will be compared to those of control MIs in environments with and without recurrent laryngeal nerve integrity. The next goal of this application is to develop a MI within a customized collagen matrix, and determine if this approach will facilitate improved alignment of muscle fibers and enhanced muscle volume when used to repair laryngeal muscle defects. To reach these goals, MIs will be created with collagen polymers exhibiting self-assembly and hierarchical engineering design of collagen fibril matrices to guide cell fate, and thereby facilitating formation of muscle fibers wih size, myofiber density, and alignment that mimics the characteristics of the native vocal fold muscle. Again, using an animal model, outcomes with the collagen based MIs will be compared to those of control MIs in environments with and without recurrent laryngeal nerve integrity. Findings from the proposed studies should overcome current major hurdles to developing a functional tissue engineered MCC for hemilaryngeal reconstruction-those hurdles being inadequate innervation of the muscle, suboptimal organization of myofibers, and asynchronous firing of the muscle with the native adductor muscle. Furthermore, results from these initial experiments should lead to landmark clinical innovations that will be relevant to both voice restoration applications, and muscle repair concepts globally.
Thousands of people in the United States each year suffer permanent voice loss because their voice boxes (larynges) are damaged from cancer, trauma, or nerve injury, as, in these cases, we currently have no options for restoration of normal laryngeal function. In this application, we explore novel methods for restoring function of the voice box (larynx) using adult-derived muscle stem cells in an animal model. We believe our findings will completely transform current paradigms for voice restoration in patients who have suffered laryngeal injuries.
| Zhang, Hongji; Voytik-Harbin, Sherry; Brookes, Sarah et al. (2018) Use of autologous adipose-derived mesenchymal stem cells for creation of laryngeal cartilage. Laryngoscope 128:E123-E129 |
| Brookes, Sarah; Voytik-Harbin, Sherry; Zhang, Hongji et al. (2018) Three-dimensional tissue-engineered skeletal muscle for laryngeal reconstruction. Laryngoscope 128:603-609 |
| Paniello, Randal C; Brookes, Sarah; Bhatt, Neel K et al. (2018) Improved adductor function after canine recurrent laryngeal nerve injury and repair using muscle progenitor cells. Laryngoscope 128:E241-E246 |
